A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome
Public ClinicalTrials.gov record NCT05946941. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome (POETYK SjS-1)
Study identification
- NCT ID
- NCT05946941
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 774 participants
Conditions and interventions
Conditions
Interventions
- Deucravacitinib Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 10, 2023
- Primary completion
- Nov 17, 2026
- Completion
- Nov 15, 2028
- Last update posted
- Mar 31, 2026
2023 – 2028
United States locations
- U.S. sites
- 28
- U.S. states
- 18
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0228 | Fullerton | California | 92835 | — |
| Local Institution - 0222 | La Palma | California | 90623 | — |
| Local Institution - 0218 | San Francisco | California | 94143 | — |
| Local Institution - 0203 | Santa Monica | California | 90404 | — |
| Local Institution - 0067 | Denver | Colorado | 80230 | — |
| Local Institution - 0049 | Clearwater | Florida | 33765 | — |
| Local Institution - 0226 | Cooper City | Florida | 33024 | — |
| Local Institution - 0223 | Sarasota | Florida | 34239 | — |
| Local Institution - 0140 | Augusta | Georgia | 30912 | — |
| Local Institution - 0229 | Lawrenceville | Georgia | 30046 | — |
| Local Institution - 0174 | Skokie | Illinois | 60076 | — |
| Local Institution - 0016 | Kansas City | Kansas | 66160 | — |
| Local Institution - 0017 | Baton Rouge | Louisiana | 70836 | — |
| Local Institution - 0125 | Monroe | Louisiana | 71203 | — |
| Local Institution - 0187 | Baltimore | Maryland | 21224-2746 | — |
| Local Institution - 0173 | Boston | Massachusetts | 02111 | — |
| Local Institution - 0131 | Eagan | Minnesota | 55123 | — |
| Local Institution - 0138 | Summit | New Jersey | 07901 | — |
| Local Institution - 0009 | Albuquerque | New Mexico | 87106 | — |
| Local Institution - 0184 | Mineola | New York | 11501 | — |
| Local Institution - 0224 | Salisbury | North Carolina | 28144 | — |
| Local Institution - 0130 | Duncansville | Pennsylvania | 16635 | — |
| Local Institution - 0022 | Jackson | Tennessee | 38305 | — |
| Local Institution - 0144 | Allen | Texas | 75013 | — |
| Local Institution - 0227 | Katy | Texas | 77494 | — |
| Local Institution - 0175 | Plano | Texas | 75024 | — |
| Local Institution - 0133 | Seattle | Washington | 98195 | — |
| Local Institution - 0189 | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 171 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05946941, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 31, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05946941 live on ClinicalTrials.gov.